S100A1 DNA-based inotropic therapy protects against proarrhythmogenic ryanodine receptor 2 dysfunction

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ritterhoff, Julia (VerfasserIn) , Völkers, Mirko (VerfasserIn) , Seitz, Andreas (VerfasserIn) , Spaich, Kristin (VerfasserIn) , Pleger, Sven Torsten (VerfasserIn) , Fink, Rainer (VerfasserIn) , Katus, Hugo (VerfasserIn) , Most, Patrick (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2015
In: Molecular therapy
Year: 2015, Jahrgang: 23, Heft: 8, Pages: 1320-1330
ISSN:1525-0024
DOI:10.1038/mt.2015.93
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1038/mt.2015.93
Volltext
Verfasserangaben:Julia Ritterhoff, Mirko Völkers, Andreas Seitz, Kristin Spaich, Erhe Gao, Karsten Peppel, Sven T. Pleger, Wolfram H. Zimmermann, Oliver Friedrich, Rainer H.A. Fink, Walter J. Koch, Hugo A. Katus and Patrick Most

MARC

LEADER 00000caa a2200000 c 4500
001 1552349187
003 DE-627
005 20230426141212.0
007 cr uuu---uuuuu
008 170126s2015 xx |||||o 00| ||eng c
024 7 |a 10.1038/mt.2015.93  |2 doi 
035 |a (DE-627)1552349187 
035 |a (DE-576)482349182 
035 |a (DE-599)BSZ482349182 
035 |a (OCoLC)1340955758 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ritterhoff, Julia  |e VerfasserIn  |0 (DE-588)1043976426  |0 (DE-627)771174101  |0 (DE-576)396460941  |4 aut 
245 1 0 |a S100A1 DNA-based inotropic therapy protects against proarrhythmogenic ryanodine receptor 2 dysfunction  |c Julia Ritterhoff, Mirko Völkers, Andreas Seitz, Kristin Spaich, Erhe Gao, Karsten Peppel, Sven T. Pleger, Wolfram H. Zimmermann, Oliver Friedrich, Rainer H.A. Fink, Walter J. Koch, Hugo A. Katus and Patrick Most 
264 1 |c August 2015 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.01.2017 
700 1 |a Völkers, Mirko  |d 1978-  |e VerfasserIn  |0 (DE-588)133026442  |0 (DE-627)530939932  |0 (DE-576)299573753  |4 aut 
700 1 |a Seitz, Andreas  |d 1988-  |e VerfasserIn  |0 (DE-588)1124177582  |0 (DE-627)877874115  |0 (DE-576)482349123  |4 aut 
700 1 |a Spaich, Kristin  |d 1984-  |e VerfasserIn  |0 (DE-588)1053015038  |0 (DE-627)78952547X  |0 (DE-576)408742348  |4 aut 
700 1 |a Pleger, Sven Torsten  |d 1973-  |e VerfasserIn  |0 (DE-588)129962473  |0 (DE-627)484985221  |0 (DE-576)297924001  |4 aut 
700 1 |a Fink, Rainer  |d 1949-  |e VerfasserIn  |0 (DE-588)131973762  |0 (DE-627)707796466  |0 (DE-576)298870142  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Most, Patrick  |d 1969-  |e VerfasserIn  |0 (DE-588)124606431  |0 (DE-627)363440267  |0 (DE-576)29440919X  |4 aut 
773 0 8 |i Enthalten in  |t Molecular therapy  |d Amsterdam : Elsevier, 2000  |g 23(2015), 8, Seite 1320-1330  |h Online-Ressource  |w (DE-627)320415198  |w (DE-600)2001818-6  |w (DE-576)104344695  |x 1525-0024  |7 nnas  |a S100A1 DNA-based inotropic therapy protects against proarrhythmogenic ryanodine receptor 2 dysfunction 
773 1 8 |g volume:23  |g year:2015  |g number:8  |g pages:1320-1330  |g extent:11  |a S100A1 DNA-based inotropic therapy protects against proarrhythmogenic ryanodine receptor 2 dysfunction 
856 4 0 |u http://dx.doi.org/10.1038/mt.2015.93  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20170126 
993 |a Article 
994 |a 2015 
998 |g 124606431  |a Most, Patrick  |m 124606431:Most, Patrick  |d 910000  |d 910100  |e 910000PM124606431  |e 910100PM124606431  |k 0/910000/  |k 1/910000/910100/  |p 13  |y j 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 131973762  |a Fink, Rainer  |m 131973762:Fink, Rainer  |d 50000  |d 53200  |e 50000PF131973762  |e 53200PF131973762  |k 0/50000/  |k 1/50000/53200/  |p 10 
998 |g 129962473  |a Pleger, Sven Torsten  |m 129962473:Pleger, Sven Torsten  |d 910000  |d 910100  |e 910000PP129962473  |e 910100PP129962473  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1053015038  |a Spaich, Kristin  |m 1053015038:Spaich, Kristin  |d 910000  |d 910100  |e 910000PS1053015038  |e 910100PS1053015038  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1124177582  |a Seitz, Andreas  |m 1124177582:Seitz, Andreas  |d 910000  |d 910100  |e 910000PS1124177582  |e 910100PS1124177582  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 133026442  |a Völkers, Mirko  |m 133026442:Völkers, Mirko  |d 910000  |d 910100  |e 910000PV133026442  |e 910100PV133026442  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1043976426  |a Ritterhoff, Julia  |m 1043976426:Ritterhoff, Julia  |d 910000  |d 910100  |e 910000PR1043976426  |e 910100PR1043976426  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1552349187  |e 2952016070 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"family":"Ritterhoff","display":"Ritterhoff, Julia","given":"Julia","role":"aut"},{"given":"Mirko","role":"aut","family":"Völkers","display":"Völkers, Mirko"},{"given":"Andreas","role":"aut","family":"Seitz","display":"Seitz, Andreas"},{"display":"Spaich, Kristin","family":"Spaich","role":"aut","given":"Kristin"},{"display":"Pleger, Sven Torsten","family":"Pleger","role":"aut","given":"Sven Torsten"},{"role":"aut","given":"Rainer","display":"Fink, Rainer","family":"Fink"},{"given":"Hugo","role":"aut","display":"Katus, Hugo","family":"Katus"},{"role":"aut","given":"Patrick","display":"Most, Patrick","family":"Most"}],"physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Julia Ritterhoff, Mirko Völkers, Andreas Seitz, Kristin Spaich, Erhe Gao, Karsten Peppel, Sven T. Pleger, Wolfram H. Zimmermann, Oliver Friedrich, Rainer H.A. Fink, Walter J. Koch, Hugo A. Katus and Patrick Most"]},"relHost":[{"recId":"320415198","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320415198"],"issn":["1525-0024"],"zdb":["2001818-6"]},"title":[{"title":"Molecular therapy","subtitle":"official journal of the American Society of Gene Therapy","title_sort":"Molecular therapy"}],"pubHistory":["1.2000 -"],"note":["Gesehen am 28.05.2020"],"origin":[{"publisherPlace":"Amsterdam ; New York, NY ; Orlando, Fla.","publisher":"Elsevier ; Nature Publ. Group ; Acad. Press","dateIssuedKey":"2000","dateIssuedDisp":"2000-"}],"disp":"S100A1 DNA-based inotropic therapy protects against proarrhythmogenic ryanodine receptor 2 dysfunctionMolecular therapy","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"part":{"extent":"11","volume":"23","pages":"1320-1330","year":"2015","text":"23(2015), 8, Seite 1320-1330","issue":"8"},"corporate":[{"role":"isb","display":"American Society of Gene Therapy"}]}],"recId":"1552349187","id":{"eki":["1552349187"],"doi":["10.1038/mt.2015.93"]},"title":[{"title":"S100A1 DNA-based inotropic therapy protects against proarrhythmogenic ryanodine receptor 2 dysfunction","title_sort":"S100A1 DNA-based inotropic therapy protects against proarrhythmogenic ryanodine receptor 2 dysfunction"}],"origin":[{"dateIssuedDisp":"August 2015","dateIssuedKey":"2015"}],"note":["Gesehen am 26.01.2017"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a RITTERHOFFS100A1DNAB2015